Emphysema Clinical Trials

A listing of Emphysema medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Birmingham Alabama 35294

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive or Pulmonary Emphysema (COPD)

Arizona

Phoenix Arizona 85013

A clinical research study of Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP) and 0.9% Sodium Chloride for Injection, USP for the treatment of Pulmonary Emphysema in Alpha-1 PI Deficiency

UPDATED

Phoenix Arizona 85012

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Tucson Arizona 85724

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

California

Peninsula Research Associates
Rolling Hills Estates California 90274

Living with COPD, emphysema or chronic bronchitis?

View More ▼

UPDATED

Fresno California 93701

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Rancho Mirage California 92270

A clinical trial to evaluate treatments using Administration of autologous adipose derived SVF

UPDATED

Riverside California 92505

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Roseville California 95825

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Sacramento California 95817

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

San Diego California 92103-8415

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive or Pulmonary Emphysema (COPD)

UPDATED

San Francisco California 94115

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Torrance California 90502

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive or Pulmonary Emphysema (COPD)

Colorado

UPDATED

Aurora Colorado 80045

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Denver Colorado 80206

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Denver Colorado 80206

Patients are needed to participate in a clinical research study to evaluate Pulmonary Disease, Chronic Obstructive or Pulmonary Emphysema (COPD)

District of Columbia

UPDATED

Washington District of Columbia 20010

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Washington District of Columbia 20007

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Florida

University of South Florida - Tampa General Hospital
Tampa Florida 33606

A Prospective, Randomized, Controlled Multicenter Clinical Study to Evaluate the Safety and Effectiveness of the IBV® Valve System for the Single Lobe Treatment of Severe Emphysema

View More ▼

UPDATED

Celebration Florida 34747

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Clearwater Florida 33765

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Gainesville Florida 32610

A clinical research study of Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP) and 0.9% Sodium Chloride for Injection, USP for the treatment of Pulmonary Emphysema in Alpha-1 PI Deficiency

UPDATED

Jacksonville Florida 32224

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Jacksonville Florida 32209

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Miami Florida 33136

A clinical research study of Alpha1-proteinase inhibitor (human), modified process (Alpha-1 MP) and 0.9% Sodium Chloride for Injection, USP for the treatment of Pulmonary Emphysema in Alpha-1 PI Deficiency

UPDATED

Miami Florida 33136

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Miami Florida 33125

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Orlando Florida 32804

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Orlando Florida 32803

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

South Miami Florida 33143

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Weston Florida 33331

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Georgia

Southeast Regional Research Group (SRRG)
Savannah Georgia 31405

Do you have COPD* (Chronic Obstructive Pulmonary Disease)

View More ▼

UPDATED

Atlanta Georgia 30322

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Austell Georgia 30106

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Dacula Georgia 30019

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Illinois

UPDATED

Chicago Illinois 60611

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Chicago Illinois 60612

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Chicago Illinois 60637

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Maywood Illinois 60153

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Indiana

UPDATED

Indianapolis Indiana 46260

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Indianapolis Indiana 46202

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Indianapolis Indiana 46250

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Kansas

UPDATED

Kansas City Kansas 66160

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Kentucky

UPDATED

Lexington Kentucky 40536

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Louisville Kentucky 40202

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

UPDATED

Louisville Kentucky 40202

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema

Louisiana

UPDATED

New Orleans Louisiana 70112

A clinical research study of Inhaled Treprostinil and Placebo for the treatment of Pulmonary Hypertension, Interstitial Lung Disease or Combined Pulmonary Fibrosis and Emphysema